About Marker Therapeutics
Investors/Media
SEC Filings
Filing date Form Description View
DEFA14A

Additional proxy soliciting materials - definitive

View HTML
10-Q

Quarterly report which provides a continuing view of a company's financial position

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
S-8

Securities offered to employees pursuant to employee benefit plans

View HTML
4

Statement of changes in beneficial ownership of securities

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
SC 13G/A

An amendment to the SC 13G filing

View HTML
424B3

Form of prospectus reflecting facts events constituting substantive change from last form

View HTML
EFFECT

EFFECT

View HTML

Data provided by Kaleidoscope.